Celastrus Orbiculatus Thunb Extract Targeting DJ-1 Inhibits Non-Small-Cell Lung Cancer Invasion and Metastasis Through Mitochondrial-Induced ROS Accumulation
暂无分享,去创建一个
Feng Wu | Yanqing Liu | Feng Jin | Haibo Wang | Shilong Yu | Xiaomin Jiang | Jun Zhou | Xiao-chen Ni | Defang Mao | X. Ni
[1] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[2] Ying Cheng,et al. Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01) , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] H. Ovaa,et al. Chemical Toolkit for PARK7: Potent, Selective, and High-Throughput , 2022, Journal of medicinal chemistry.
[4] M. Grãos,et al. Modulation of signaling pathways by DJ-1: An updated overview , 2022, Redox biology.
[5] O. Buneeva,et al. DJ-1 Protein and Its Role in the Development of Parkinson’s Disease: Studies on Experimental Models , 2021, Biochemistry (Moscow).
[6] S. Pauklin,et al. ROS and TGFβ: from pancreatic tumour growth to metastasis , 2021, Journal of experimental & clinical cancer research : CR.
[7] Yayun Qian,et al. COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis , 2021, Frontiers in Pharmacology.
[8] Liu Gaofeng,et al. Traditional Chinese medicine and lung cancer--From theory to practice. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] A. Whitworth,et al. DJ-1: A promising therapeutic candidate for ischemia-reperfusion injury , 2021, Redox biology.
[10] N. Hattori,et al. Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease , 2020, Frontiers in Neurology.
[11] Lei Zhou,et al. Multidisciplinary and Comprehensive Chinese Medicine for Advanced Non-Small Cell Lung Cancer Patients: A Retrospective Study of 855 Cases , 2020, Chinese Journal of Integrative Medicine.
[12] Yang Li,et al. Artificial intelligence in gastric cancer: a systematic review , 2020, Journal of Cancer Research and Clinical Oncology.
[13] E. Tan,et al. Historical Perspective: Models of Parkinson’s Disease , 2020, International journal of molecular sciences.
[14] Xiongwei Zhu,et al. DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1 , 2019, Proceedings of the National Academy of Sciences.
[15] Q. Zhang,et al. Traditional uses, secondary metabolites, and pharmacology of Celastrus species - a review. , 2019, Journal of ethnopharmacology.
[16] Joel S. Bader,et al. E-cadherin is required for metastasis in multiple models of breast cancer , 2019, Nature.
[17] Li-Zhu Lin,et al. Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study , 2019, Chinese Journal of Integrative Medicine.
[18] Li Tao,et al. Cytotoxic abietane and kaurane diterpenoids from Celastrus orbiculatus , 2019, Journal of Natural Medicines.
[19] K. Kerr,et al. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC , 2019, Nature Reviews Clinical Oncology.
[20] Yitao Wang,et al. DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis , 2018, Cell Death & Disease.
[21] Xia-Wei Zhang,et al. Chinese Herbal Medicine for Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. , 2018, The American journal of Chinese medicine.
[22] J. Chan,et al. Activation of endogenous antioxidants as a common therapeutic strategy against cancer, neurodegeneration and cardiovascular diseases: A lesson learnt from DJ-1. , 2015, Pharmacology & therapeutics.
[23] Bo Yang,et al. DJ-1 as a human oncogene and potential therapeutic target. , 2015, Biochemical pharmacology.
[24] T. Mak,et al. Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.
[25] A. M. van der Bliek,et al. Mitochondrial Fission, Fusion, and Stress , 2012, Science.
[26] J. Nunnari,et al. Mitochondria: In Sickness and in Health , 2012, Cell.
[27] S. Courtneidge,et al. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function , 2011, Nature Reviews Molecular Cell Biology.
[28] Peng Huang,et al. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.
[29] T. Mak,et al. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 , 2006, Proceedings of the National Academy of Sciences.
[30] M. Cameron Sullards,et al. Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases* , 2006, Journal of Biological Chemistry.
[31] Wenbo Zhou,et al. DJ-1 Up-regulates Glutathione Synthesis during Oxidative Stress and Inhibits A53T α-Synuclein Toxicity* , 2005, Journal of Biological Chemistry.
[32] T. Mak,et al. DJ-1, a novel regulator of the tumor suppressor PTEN. , 2005, Cancer cell.
[33] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[34] G. Di Trapani,et al. The Multifaceted Roles of DJ-1 as an Antioxidant. , 2017, Advances in experimental medicine and biology.
[35] Qiaojun He,et al. DJ-1 as a Therapeutic Target Against Cancer. , 2017, Advances in experimental medicine and biology.
[36] Liquid Biopsies. Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.
[37] V. A. Flørenes,et al. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. , 2008, Human pathology.